Tagged with HE

France Thomas Courbe, Director General for Enterprise at the French Ministry of Economy and Finance, has led France’s industrial transformation since 2019. He oversees, within the EURO 54 billion France 2030 plan, reforms in manufacturing, decarbonisation, and digital innovation. Under his leadership, France has become a top destination for foreign investment,…

USA What if ageing itself, not just individual diseases, was the root cause of the most devastating conditions we face? That question has shaped the career of Dr. Joshua Hare, a practising cardiologist and biotech founder who is betting on stem cell therapy to shift how we treat age-related illnesses. Dr.…

Global Alzheimer’s Disease takes a heavy toll; not just on patients and caregivers, but on society as a whole. As populations age, this complex and often-stigmatised condition is becoming harder to ignore. Despite recent breakthroughs, we are still far from having the right tools: better diagnostics, effective treatments, and smarter healthcare…

Switzerland Doetsch Grether may be 126 years old, but it is anything but traditional. With a portfolio that spans pharmaceuticals, consumer health, and retail – an uncommon mix for a company of its size – the Swiss firm is doubling down on focused expansion, values-driven culture, and long-term partnerships. For Wannhoff,…

Denmark As clinical trials increasingly drift toward Asia and the US, can Denmark offer a blueprint for revitalising Europe’s competitive edge?   As Europe’s leader in clinical trials per capita, Denmark combines a deep domestic commitment to cutting-edge research with strong international confidence as a destination for investment. In 2023, the…

Switzerland In a milestone for global health, Novartis has received Swissmedic approval for Coartem Baby, the world’s first antimalarial treatment tailored for newborns and infants under 4.5kg. The decision fills a long-standing therapeutic gap and reinforces the company’s commitment to diseases that fall outside the pharmaceutical industry’s traditional commercial priorities.  …

Puerto Rico Puerto Rico’s healthcare system is a paradox of strength and fragility. With one of the highest insurance coverage rates in the US (around 94 percent) and a long tradition of medical excellence, it has also faced persistent funding gaps and a growing exodus of talent. Now, new federal policy shifts…

Belgium The latest stories from healthcare and the life sciences in Belgium, the Netherlands and Luxembourg (BeNeLux). UCB is considering a USD five billion investment in the US to avoid President Trump’s tariffs on the EU; Belgium’s competition authority fines three consumer healthcare companies; and the launch of a EUR 200…

Switzerland Over the past decade, Dr Lutz Hegemann has helped transform Novartis’ Global Health unit into a strategic pillar that bridges innovation with real-world access. Rather than focusing on visibility, the mandate centres on sustainable impact; embedding access into R&D, rethinking the value of established medicines, and advocating for systemic change…

Puerto Rico Víctor Ramos Otero, Secretary of Health for Puerto Rico, reflects on his first 100 days in office and the key initiatives to strengthen the island’s healthcare system. He discusses efforts to address the exodus of healthcare professionals, improve access to care through telemedicine and new legislation, and combat disparities in…

Switzerland Hanns-Christian Mahler, founder and CEO of Swiss-based CDMO ten23 health, outlines his vision for a next-generation contract development and manufacturing organisation. With a career spanning Merck, Roche, and Lonza, he emphasises expertise-driven partnerships, agile decision-making, and sustainability as core differentiators. Since its 2021 launch, ten23 health has rapidly scaled its…

Denmark Neuroscience is once again at the forefront of medical innovation, and Lundbeck is seizing the moment to redefine its future. In this wide-ranging conversation, President & CEO Charl van Zyl outlines how the company is evolving from a heritage-rich organisation into a focused, performance-driven innovator with a maturing pipeline and…